Related Experiment Video

Updated: Jun 23, 2026

A Practical Guide for the Production and PET/CT Imaging of 68Ga-DOTATATE for Neuroendocrine Tumors in Daily Clinical Practice
08:55

A Practical Guide for the Production and PET/CT Imaging of 68Ga-DOTATATE for Neuroendocrine Tumors in Daily Clinical Practice

Published on: April 17, 2019

Options for gastroenteropancreatic neuroendocrine tumours

Feng Yang, Chen Jin, Jiang Long

    The Lancet. Oncology
    |March 1, 2008
    PubMed
    Abstract

    No abstract available in PubMed .

    More Related Videos

    Robotic Enucleation of an Intra-Pancreatic Insulinoma in the Pancreatic Head
    05:42

    Robotic Enucleation of an Intra-Pancreatic Insulinoma in the Pancreatic Head

    Published on: January 3, 2020

    Establishment and Characterization of Small Bowel Neuroendocrine Tumor Spheroids
    09:43

    Establishment and Characterization of Small Bowel Neuroendocrine Tumor Spheroids

    Published on: October 14, 2019

    Related Experiment Videos

    Last Updated: Jun 23, 2026

    A Practical Guide for the Production and PET/CT Imaging of 68Ga-DOTATATE for Neuroendocrine Tumors in Daily Clinical Practice
    08:55

    A Practical Guide for the Production and PET/CT Imaging of 68Ga-DOTATATE for Neuroendocrine Tumors in Daily Clinical Practice

    Published on: April 17, 2019

    Robotic Enucleation of an Intra-Pancreatic Insulinoma in the Pancreatic Head
    05:42

    Robotic Enucleation of an Intra-Pancreatic Insulinoma in the Pancreatic Head

    Published on: January 3, 2020

    Establishment and Characterization of Small Bowel Neuroendocrine Tumor Spheroids
    09:43

    Establishment and Characterization of Small Bowel Neuroendocrine Tumor Spheroids

    Published on: October 14, 2019

    Related Concept Videos

    Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists01:28

    Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists

    Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy.  SP binds and activates these...
    Enteral Nutrition II: Nasointestinal and Gastrostomy Feeding01:15

    Enteral Nutrition II: Nasointestinal and Gastrostomy Feeding

    Enteral nutrition encompasses various methods of delivering nutrition directly to the gastrointestinal (GI) tract, bypassing traditional oral intake. It is particularly beneficial for patients who cannot eat by mouth but have a functioning digestive system. Key methods include nasointestinal feeding, gastrostomy, and jejunostomy, each suited to different clinical scenarios based on the patient's needs and condition.
    Nasointestinal Feeding
    Nasointestinal feeding involves placing a tube through...

    Articles linked to this work by shared authors, journal, and citation graph.

    Incremental Value of Synthetic MRI Radiomics in Predicting Neoadjuvant Response in Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer.

    Radiology. Imaging cancer·2026

    Parenchyma-sparing pancreatectomy for solid pseudopapillary neoplasm of the pancreas: A propensity-matched analysis.

    Surgery·2026

    Microenvironment-bionic scaffold and multi-cell spatial patterning for area-specific meniscus regeneration.

    Biomaterials·2026

    Single-cell atlas of the mouse ovary reveals molecular drivers of aging and senescence during the estropausal transition.

    Proceedings of the National Academy of Sciences of the United States of America·2026

    HRD Score: A Promising Biomarker for Genomic Instability Evaluation for Targeted Treatments Among Pancreatic Cancer Patients.

    Technology in cancer research & treatment·2026

    Ubiquitination of ACSL4 by Parkin Suppresses Ferroptosis and Rescues Glucocorticoid-Induced Bone Loss.

    Advanced science (Weinheim, Baden-Wurttemberg, Germany)·2026

    Local management of second ipsilateral breast cancer events after primary breast-conserving therapy: an international Delphi consensus.

    The Lancet. Oncology·2026

    Consensus statements from the first Gynecologic Cancer InterGroup Cervical Cancer Consensus Conference in Clinical Research.

    The Lancet. Oncology·2026

    Advancing oncology education in low-income and middle-income African settings: global insights for local action.

    The Lancet. Oncology·2026

    Intravesical cretostimogene grenadenorepvec oncolytic immunotherapy in high-risk, BCG-unresponsive, non-muscle-invasive bladder cancer with carcinoma in situ (BOND-003 Cohort C): a single-arm, phase 3 trial.

    The Lancet. Oncology·2026

    Postmastectomy chest wall radiotherapy for breast cancer (SUPREMO): 5-year quality-of-life results from a randomised, controlled, phase 3 trial.

    The Lancet. Oncology·2026

    Addition of irinotecan to chemoradiotherapy as preoperative treatment for locally advanced rectal cancer (ARISTOTLE): a multicentre, open-label, phase 3, randomised controlled trial.

    The Lancet. Oncology·2026

    Primary myoepithelial carcinoma of the gallbladder: a case report and literature review.

    Frontiers in oncology·2026

    Unusual dual malignancy: basaloid squamous cell carcinoma arising from inverted papilloma with contralateral temporal bone carcinoma.

    BMJ case reports·2026

    Optimising Clinical Outcomes Following R1 Resection in Soft Tissue Sarcoma: An Evidence-Based Approach.

    Current treatment options in oncology·2026

    A Staged Hybrid Technique for Large Benign Colorectal Polyps with Severe Fibrosis: A Retrospective Cohort Study.

    Endoscopy international open·2026

    A Cardiac Time Bomb: Stroke as the Initial Presentation of a Large Atrial Myxoma.

    Cureus·2026

    New progress and clinical research translation of immune checkpoint inhibitors in systemic therapy of gallbladder cancer.

    Frontiers in immunology·2026
    See all related articles
    JoVE
    x logofacebook logolinkedin logoyoutube logo
    ABOUT JoVE
    OverviewLeadershipBlogJoVE Help Center
    AUTHORS
    Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
    LIBRARIANS
    TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
    RESEARCH
    JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
    EDUCATION
    JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
    Terms & Conditions of Use
    Privacy Policy
    Policies
    Jove
    Visualize
    Contact Us